The latest headlines across every section, pulled from official and open-access sources.
This cohort study comprising 12.6 million women evaluates the differential association of dense breast notification and insurance coverage laws with supplemental imaging use and assesses how specific legislative features are associated with imaging use.
This survey study of Los Angeles County residents, conducted before and after the January 2025 wildfires, estimates the association between wildfire exposure and psychological distress and assesses the social factors that modify this association.
This cohort study uses registry data to analyze health care utilization profiles among young Ukrainian refugee children who accessed the health care system in southern Poland in 2022.
This cohort study examines trends and variation in uptake of next-generation sequencing (NGS) and non-NGS genomic testing among Medicare beneficiaries with common cancers using the Chronic Conditions Data Warehouse.
This survey study uses a participatory priority-setting process to identify the most important unanswered research questions in pediatric migrant health among migrant and clinician stakeholders in Europe.
This cross-sectional study investigates the design, conduct, and analysis of Chinese herbal medicine randomized clinical trials (RCTs) and examines whether there are differences between RCTs published in English and Chinese.
Throne Science — a startup selling an AI-powered toilet camera that tracks gut health, hydration and urinary function — closed a $10 million Series A funding round. CEO Scott Hickle said the goal is to become a “smoke detector for colorectal cancer,” filling a monitoring gap he noted the wearables industry has largely ignored. The post Smart Toilet Sensor Startup Is Flush with $10M Funding appeared first on MedCity News .
Included Health announced plans to acquire Firefly Health to accelerate its alternative health plan strategy for employers. The post Included Health to Acquire Firefly Health to Expand Alternative Health Plan Offering for Employers appeared first on MedCity News .
Altimmune’s pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide drug, which is designed to activate the GLP-1 and glucagon receptors, is also on track to begin a pivotal test in the fatty liver disease MASH. The post Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial appeared first on MedCity News .
A Letter from the American Diabetes Association Audit & Governance Committee (AGC) vcramer Tue, 07/28/2026 - 20:34 Organizational Updates A Letter from the American Diabetes Association Audit & Governance Committee (AGC) Arlington, Va. July 28, 2026 Dear ADA community: In the aftermath of the difficulty that our community experienced at the New Orleans Scientific Sessions last month, I wanted to make sure you are aware of the processes we’re working through and what you can expect to see from the Board of Directors in the weeks ahead. The events of our New…
The course will take place Sept. 28 to 29, 2026, at ACP headquarters in Philadelphia.
Only one month of dual antithrombotic therapy followed by direct oral anticoagulant (DOAC) monotherapy proved to be noninferior in terms of efficacy and superior in terms of bleeding outcomes to the standard 12-month dual antithrombotic therapy post PCI among patients with atrial fibrillation (AFib), according to results of the OPTIMA-AF trial published July 15 in The Lancet.
Information related to upcoming new and revised product-specific guidances (PSGs) to support the development and approval of safe and effective complex generic drug products.
This report describes 968 potential cases of invasive mold disease across four Georgia hospitals.
In this interview, Steven E. Nissen MD, MACC David H. Wiener, MD, FACC discuss practice-changing advancements in echocardiography.
The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product lines.
Levels of microplastics and nanoplastics (MNPs) in coronary blood were higher in patients with a STEMI than those with chronic coronary syndromes (CCS) or in controls, according to a cross-sectional study published July 14 in the EHJ.
The company recovered 186 million euros after it “largely completed the U.S. tariff refund process” in the quarter, CEO Roy Jakobs said on an earnings call.
by Elisabeth Leirgul, Gottfried Greve Advances in medical and surgical treatment of congenital heart disease (CHD) now allows most affected individuals to reach adulthood and parenthood. While maternal CHD is associated with pregnancy complications, emerging evidence suggests a possible increased risk of developmental challenges in offspring, particularly among children of mothers with severe CHD. In this Perspective, Elisabeth Leirgul and Gottfried Greve discuss emerging evidence that as well as maternal congenital heart disease (CHD) being associated with pregnancy complications, there is…
Done well, NICU UM is so much more than an approval process. It is a clinical credibility engine that — when integrated with Case Management (CM) — drives every NICU admission toward the most appropriate, impactful care. The post Why Specialized UM Delivers on Every NICU Outcome appeared first on MedCity News .
In patients with severe secondary tricuspid regurgitation (TR), tricuspid valve transcatheter edge-to-edge repair (T-TEER), compared with transcatheter tricuspid valve annuloplasty (TTVA), showed a more favorable safety profile and a more effective and durable reduction in TR, while clinical outcomes at one year were similar with both strategies, according to research published July 22 in JACC: Advances.
A few minutes of interaction with a digital tablet and speaking can reveal patterns that once required advanced imaging, years of observation, or were just completely undetectable. The post Spotting Alzheimer’s Years Earlier Through AI and Clinically Meaningful Insights appeared first on MedCity News .
Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural Pipeline-to-Patient Productivity Index, which evaluated 25 large, global biopharma companies on R&D productivity, market access and commercial performance.
Today, the Food and Drug Administration published 17 revised draft product-specific guidances (PSGs) for peptide products, marking Today, the Food and Drug Administration published 17 revised draft product-specific guidances (PSGs) for peptide products.